ICMR-National Institute of Cholera and Enteric Diseases

आई सी एम आर - राष्ट्रीय कॉलरा और आंत्र रोग संस्थान

Department of Health Research, Ministry of Health and Family Welfare, Government of India
स्वास्थ्य अनुसंधान विभाग, स्वास्थ्य और परिवार कल्याण मंत्रालय, भारत सरकार
WHO Collaborating Centre For Research and Training On Diarrhoeal Diseases

NICED : News


Posted : 26 Nov 2020
COVAXIN Phase III Trial : Request for participation

In pursuance to the letter from ICMR Hqrs. No.VIR/COVID-19/39/2020/ECD-1 dated 29/10/2020, it is to be informed that ICMR-NICED has been selected as one of the sites for conducting CDSCO approved regulatory trial entitled "An Event-driven, Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter study to evaluate the efficacy, safety, immunogenicity and Lot-to-Lot consistency of BBV 152, a Whole-virion inactivated SARS-CoV-2 vaccine in adults ≥18 years of age". The trial will be carried out among volunteers to evaluate the efficacy of inactivated SARS-CoV2 vaccine against COVID-19 infection in adults more than 18 years of age to prevent symptomatic COVID-19. Participants residing in Kolkata (preferably within 10 KM of ICMR-NICED, Beliaghata) are encouraged to become the volunteers in this trial. Those who are willing to participate in this trial are instructed to send their requests over the number +919836169622 or email at bbv152niced@gmail.com  with their personal details (name, age, sex, address, contact number, email and comorbidities, if any) for consideration. As per trial protocol, limited number of participants will be enrolled in this trial after screening for their eligibility criteria. The eligible participants will be contacted for further details over the given Mobile/Email. Participants enrollment will continue until the target number is achieved.


Dated: 02 April 2020


  • Regional VRDL, ICMR-NICED is a designated centre for testing of COVID-19, presently catering to the states of Sikkim and West Bengal.
  • The Govt. approved testing centres of West Bengal and their district-wise linkage are mentioned in Annexure I.
  • The properly collected, labelled and packaged clinical samples SHOULD BE SENT ONLY AFTER DUE INTIMATION TO THE NODAL PERSONS OF THE CORRESPONDING STATE HEALTH DEPARTMENTS (for WB refer Annexure I, www.wbhealth.gov.in  ).
  • The strategy of COVID-19 testing in India laid by DHR/ICMR/MoH&FW and updated from time to time should be followed for selection of cases.
  • Each sample should be accompanied by properly filled in Specimen Referral Form (Annexure II)
  • Guidelines regarding sample collection, packaging and transport (Annexure III).
  • Nodal Persons at Regional VRDL, ICMR-NICED (for any query regarding testing only):
    Dr. Ananya Chatterjee, 9933135866
    Dr. Agniva Majumdar, 9433756755




Posted : 02 Apr 2020

View COVID-19 Guidelines: Information Regarding Testing of Samples for SARS-CoV-2 in the Emergency Situation


Posted : 11 Mar 2020

 View  COVID Guidelines...

Rotavirus Vaccine Interchangeability Trial Begins Enrolling Participants in Kolkata, India

Posted : 24 Mar 2019

Rotavirus Vaccine Interchangeability Trial Begins Enrolling Participants in Kolkata, India

Diarrhoeal disease is one of the most important causes of illness and death among under five years children and Rotavirus is the most common agent causing acute watery diarrhoea in that age group. Rotavirus diarrhoea poses a major public health challenge, especially due to the dehydration caused by acute diarrhoea and vomiting, delayed health seeking behaviours of the caregivers of affected children, and lack of primary healthcare facilities in the vicinity of community settings. View Details...

14th ASCODD conference

Posted : 10 Aug 2017

14th ASCODD conference will be held during 30th October 2017 - 1st November 2017 at Kochi. Scientists and students interested to participate in the conference please check the link given here under http://www.ascodd.net/ 


Notice regarding Merit Based Assessment Promotion Scheme (MBAPS). Dated 19 Sep 2016
View Notice

NICED Microbiology and Serology laboratory received accreditation in the field of MEDICAL TESTING under 'National Accreditation Board for Testing and Calibration Laboratories (NABL)' ; ISO 15189:2012; Medical laboratories-Requirements for quality and competence.
Please click for 'Scope of accreditation'.


Mr. Angesom Abraham Gebremeskel (on the left) with Dr. A. K. Mukhopadhyay, Scientist-E from NICED.


Dr. Keya Sen (from extreme left) with Director and other scientists of NICED and visitors

National & International Visitors Worked at NICED

Name of the Visitors Institute and Country Name of the Fellowship Period of fellowship Worked at NICED with
Mr. Angesom Abraham Gebremeskel Lecturer in Department of Biology
College of Science
Eritrea Institute of Technology
Asmara, Eritrea
NAMS&T Centre Research Training Fellowship
for Developing Country Scientists (RTF-DCS)
Six months (February 18 to August 12, 2016) Dr. Asish Kr. Mukhopadhyay, Scientist-E
Dr. Keya Sen Scientific Advisor & Part-time lecturer
School of Science, Technology, Engineering and Mathematics
University of Washington I Bothell
Box 358538, 10909 NE 185th Street,
Bothell, WA 98011
Fullbright Global Flex Award (Research) Two months ( July 19 to September 16, 2016) Dr. Asish Kr. Mukhopadhyay, Scientist-E
Dr. Jeffrey H. Withey Associate Professor
Department of Immunology and Microbiology
School of Medicine
Wayne State University
Detroit, MI
Fullbright - Nehru Fellowship Five months (November 2014 to March 2015) Dr. Hemanta Koley,
Dr. Akinsinde Kehinde Adewale Assistant Chief Medical Laboratory Scientist,Nigerian Institute of Medical Research (NIMR) Molecular Biology and Biotechnology Department, 6 Edmund Crescent, Murtala Mohammad way, P.M.B. 2013, Yaba, Lagos, Nigeria JNCASR-CICS Fellowship
[Centre for International Co-operation in Science (CICS), Chennai and Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) jointly operate JNCASR-CICS Fellowship]
Three months (June to August 2011). Dr. T. Ramamurthy,